📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RevGenUK, the next generation: establishing a TILLING boutique for a UK-based reverse genetics community resource

Lead Research Organisation: Earlham Institute
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

TILLING (Targeting Induced Local Lesions in Genomes) is a non-GM reverse genetics technology for discovering, characterising and exploiting genetic variation, based on mutation detection. Reverse genetics is a strategy whereby plants carrying mutations in target genes are identified and then phenotyped, in order to determine the function of those genes. RevGenUK is a global TILLING service previously established for Medicago truncatula and Brassica rapa. The aim of this project is to expand the species range and to implement TILLING-by-sequencing as the strategy for mutation detection.
Recent advances in next generation sequencing (NGS) throughput, the ability to barcode and pool samples prior to sequencing, and increased read-lengths have made TILLING-by-sequencing a practical alternative to conventional TILLING. In addition the use of exome capture approaches allow the targeted sequencing of regions of interest within the genome. Reducing the fraction of the genome to be sequenced, enables increased multiplexing of samples, and a reduction in both cost and analysis time. Over one thousand mutagenised lines of B. rapa will undergo exome capture, resequencing and analysis to detect mutations within the captured gene regions. These mutations will be displayed within a web-accessible database enabling community access to these materials. These developments will enable RevGenUK to provide a high throughput, efficient and cost effective service at the cutting edge of reverse genetics technologies.

Planned Impact

unavailable

Publications

10 25 50